Literature DB >> 6581829

Testicular relapse in acute lymphoblastic leukaemia: studies with an experimental mouse model.

H Jackson, N C Jackson, M Bock, M Lendon.   

Abstract

Neither testis nor epididymis was found to be invaded by L1210 leukaemic cells in spite of widespread dissemination through other organs and tissues. The same applied to animals in relapse after protracted remissions induced by cyclophosphamide. Prior damage to the gonadal vascular endothelium by Cd++ did enable leukaemic cells to enter the testicular interstitium, but not the depleted seminiferous tubules. Injection of cells into the lymphatic sinus system of the testis led to rapid peritubular proliferation and systemic dissemination but the seminiferous tubules were not penetrated. The histological appearance resembled that of human ALL. The results suggest that the L1210 system, using the intratesticular route for inoculation can be used to examine the susceptibility to drugs of leukaemic cells in this environment. The potential of drugs to damage the vascular endothelium of the gonad and perhaps contribute to the development of testicular relapse could be assessed following intramuscular inoculation of cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6581829      PMCID: PMC1976668          DOI: 10.1038/bjc.1984.11

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  DEVELOPMENT OF MENINGEAL LEUKEMIA (L1210) DURING TREATMENT OF SUBCUTANEOUSLY INOCULATED MICE WITH METHOTREXATE.

Authors:  L B THOMAS; M A CHIRIGOS; S R HUMPHREYS; A GOLDIN
Journal:  Cancer       Date:  1964-03       Impact factor: 6.860

2.  Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan.

Authors:  L B THOMAS; M A CHIRIGOS; S R HUMPHREYS; A GOLDIN
Journal:  J Natl Cancer Inst       Date:  1962-06       Impact factor: 13.506

3.  The penetration of iodine-labelled follicle-stimulating hormone and albumin into the seminiferous tubules of sheep and rats.

Authors:  B P Setchell; A L Wallace
Journal:  J Endocrinol       Date:  1972-07       Impact factor: 4.286

4.  New approaches in administration of anticancer drugs.

Authors:  D P Rall
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

5.  Acute cadmium-induced changes in the energy metabolism of the rat testis.

Authors:  M Härkönen; M Kormano
Journal:  J Reprod Fertil       Date:  1970-03

6.  Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome.

Authors:  J Tiedemann; J M Chessells; R M Sandland
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

7.  Comparative observations on intertubular lymphatics and the organization of the interstitial tissue of the mammalian testis.

Authors:  D W Fawcett; W B Neaves; M N Flores
Journal:  Biol Reprod       Date:  1973-12       Impact factor: 4.285

8.  Changes in blood flow and vascular permeability of the testis, epididymis and accessory reproductive organs of the rat after the administration of cadmium chloride.

Authors:  G M Waites; B P Setchell
Journal:  J Endocrinol       Date:  1966-03       Impact factor: 4.286

9.  Permeability of selected drugs and chemicals across the blood-testis barrier of the rat.

Authors:  K Okumura; I P Lee; R L Dixon
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

10.  A blood-testis barrier restricting passage from blood into rete testis fluid but not into lymph.

Authors:  B P Setchell; J K Voglmayr; G M Waites
Journal:  J Physiol       Date:  1969-01       Impact factor: 5.182

View more
  2 in total

1.  A rodent model for testicular involvement in acute lymphoblastic leukaemia.

Authors:  K Jahnukainen; I Morris; S Roe; T T Salmi; A Mäkipernaa; P Pöllänen
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

2.  Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia.

Authors:  H Jackson; N C Jackson; M Bock; M Lendon
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.